Early studies determined that LMO2 is a key regulator of embryonic hematopoiesis and angiogenesis3, 4, 5 and an oncogene that can trigger T-ALL in both humans and transgenic mouse models6, 7, 8. Here, LMO2 is linked to acute lymphoblastic leukemia.